Blozo, Raymund A.
HRN: 27-32-46 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/15/2025
CEFUROXIME 750MG (VIAL)
06/15/2025
06/21/2025
IV
750mg
Q8
S/p Appendectomy
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes